Shyam PatelDirector Business Development at California Institute for Regenerative Medicine
Shyam Patel currently serves as Director of Business Development at CIRM. CIRM has deployed $2.7 billion to fund over 1000 cell, gene and regenerative medicine therapy development programs (120+ currently active) including 64 clinical trials. At CIRM, Shyam manages CIRM’s Business Development activities, the Industry Alliance Program (IAP) and collaborations with NHLBI, CZI, FCDI and others. The IAP is a collaborative effort between CIRM and select industry partners to support development and commercialization of CIRM’s most promising portfolio projects. Prior to joining CIRM, Shyam led preclinical development of tissue-engineered graft implants as the CSO/Acting CEO of NanoNerve, Inc. He also served as part-time Bioengineering faculty at UC Berkeley. Shyam holds a Ph.D. in Bioengineering from the Universities of California, Berkeley & San Francisco.